Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank100
Studio
Year-over-Year Change

Free cash flow yield

Latest
16.42%
↑ 176% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-21.48%
Historical baseline
PeriodValueYoY Change
202516.42%+261.8%
2024-10.15%-0.9%
2023-10.06%+85.5%
2022-69.47%-3.0%
2021-67.46%-136.3%
2020-28.55%+19.1%
2019-35.29%-130.2%
2018-15.33%-71.6%
2017-8.93%-163.5%
201614.07%-